EF
MEDP icon

Empirical Finance’s Medpace MEDP Stock Holding History

Empirical Finance’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Sell
10,782
-1,881
-15% -$868K 0.24% 83
2026
Q1 		$6.08M Buy
12,663
+5,667
+81% +$2.9M 0.29% 73
2025
Q4 		$3.93M Buy
6,996
+1,800
+35% +$1.02M 0.19% 103
2025
Q3 		$2.67M Sell
5,196
-1,778
-25% -$776K 0.13% 146
2025
Q2 		$2.19M Buy
6,974
+2,928
+72% +$879K 0.11% 167
2025
Q1 		$1.23M Buy
+4,046
New +$1.36M 0.07% 238

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Empirical Finance's MEDP Position: Q2 2026 in Review

Empirical Finance reduced its Medpace (MEDP) stake by 15% in Q2 2026, selling an estimated $868K and leaving 10,782 shares worth $5.71M. The position accounts for 0.24% of the portfolio, ranked #83.

Empirical Finance first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.08M in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Empirical Finance held 10,782 shares of Medpace worth $5.71M as of Q2 2026.
  • Empirical Finance sold 1,881 Medpace shares in Q2 2026, an estimated $868K.
  • Medpace made up 0.24% of Empirical Finance's portfolio in Q2 2026, its #83 holding.
  • Empirical Finance first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Empirical Finance's Medpace position peaked at $6.08M in Q1 2026.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.